Article Versions Notes

Klatt D, Ha T-C, Schinke M, Selich A, Lieske A, Dahlke J, Morgan M, Maetzig T, Schambach A. Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment. Cells. 2020; 9(10):2194. https://doi.org/10.3390/cells9102194

Klatt, Denise, Teng-Cheong Ha, Maximilian Schinke, Anton Selich, Anna Lieske, Julia Dahlke, Michael Morgan, Tobias Maetzig, and Axel Schambach. 2020. "Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment" Cells 9, no. 10: 2194. https://doi.org/10.3390/cells9102194

Klatt, D., Ha, T. -C., Schinke, M., Selich, A., Lieske, A., Dahlke, J., Morgan, M., Maetzig, T., & Schambach, A. (2020). Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment. Cells, 9(10), 2194. https://doi.org/10.3390/cells9102194